Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manish Jha

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
The American Journal of Medicine|May 29, 2023
Association of Depression and Cardiovascular DiseaseChayakrit Krittanawong, Neil Sagar Maitra, Yusuf Kamran Qadeer, et al.
The American Journal of Medicine|April 28, 2024
The ReplyChayakrit Krittanawong, Neil Sagar Maitra, Yusuf Kamran Qadeer, et al.
Journal of Affective Disorders|January 25, 2026
Symptom trajectories and clinical outcomes of intravenous ketamine in treatment-resistant depression: A real-world study using group-based trajectory modelingReinhard Janssen-Aguilar, Jithin Joseph, Huda Al-Shamali, et al.
Psychiatry Research|June 9, 2026
Symptom trajectories and treatment outcomes following a five-day accelerated intermittent-theta burst stimulation protocol for treatment-resistant depression: A naturalistic study in a real-world settingReinhard Janssen-Aguilar, Jithin Joseph, Huda F Al-Shamali, et al.
Journal of Affective Disorders|February 22, 2023
Psychometric evaluation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR<sub>9</sub>) (a measure of suicidal risk) in adolescent psychiatric outpatients in the Texas Youth Depression and Suicide Research Network (TX-YDSRN)Karabi Nandy, A John Rush, Holli Slater, et al.
Brain Stimulation|October 15, 2017
Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
CNS Spectrums|May 23, 2023
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 reportM Ishrat Husain, Jane A Foster, Brittany L Mason, et al.
Indian Heart Journal|March 14, 2021
Design and rationale of an intelligent algorithm to detect BuRnoUt in HeaLthcare workers in COVID era using ECG and artificiaL intelligence: The BRUCEE-LI studyMohit D Gupta, Ankit Bansal, Prattay G Sarkar, et al.
American Journal of Preventive Cardiology|June 6, 2025
South Asians and cardiometabolic health: A framework for comprehensive care for the individual, community, and population - An American society for preventive cardiology clinical practice statementAnand Rohatgi, Sonia S Anand, Meghana Gadgil, et al.
Eclinicalmedicine|June 14, 2019
Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC TrialCrystal M Cooper, Cherise R Chin Fatt, Manish Jha, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
The American Journal of Medicine|May 29, 2023
Association of Depression and Cardiovascular DiseaseChayakrit Krittanawong, Neil Sagar Maitra, Yusuf Kamran Qadeer, et al.
The American Journal of Medicine|April 28, 2024
The ReplyChayakrit Krittanawong, Neil Sagar Maitra, Yusuf Kamran Qadeer, et al.
Journal of Affective Disorders|January 25, 2026
Symptom trajectories and clinical outcomes of intravenous ketamine in treatment-resistant depression: A real-world study using group-based trajectory modelingReinhard Janssen-Aguilar, Jithin Joseph, Huda Al-Shamali, et al.
Psychiatry Research|June 9, 2026
Symptom trajectories and treatment outcomes following a five-day accelerated intermittent-theta burst stimulation protocol for treatment-resistant depression: A naturalistic study in a real-world settingReinhard Janssen-Aguilar, Jithin Joseph, Huda F Al-Shamali, et al.
Journal of Affective Disorders|February 22, 2023
Psychometric evaluation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR<sub>9</sub>) (a measure of suicidal risk) in adolescent psychiatric outpatients in the Texas Youth Depression and Suicide Research Network (TX-YDSRN)Karabi Nandy, A John Rush, Holli Slater, et al.
Brain Stimulation|October 15, 2017
Double-blind, proof-of-concept (POC) trial of Low-Field Magnetic Stimulation (LFMS) augmentation of antidepressant therapy in treatment-resistant depression (TRD)Maurizio Fava, Marlene P Freeman, Martina Flynn, et al.
CNS Spectrums|May 23, 2023
Pro-inflammatory markers are associated with response to sequential pharmacotherapy in major depressive disorder: a CAN-BIND-1 reportM Ishrat Husain, Jane A Foster, Brittany L Mason, et al.
Indian Heart Journal|March 14, 2021
Design and rationale of an intelligent algorithm to detect BuRnoUt in HeaLthcare workers in COVID era using ECG and artificiaL intelligence: The BRUCEE-LI studyMohit D Gupta, Ankit Bansal, Prattay G Sarkar, et al.
American Journal of Preventive Cardiology|June 6, 2025
South Asians and cardiometabolic health: A framework for comprehensive care for the individual, community, and population - An American society for preventive cardiology clinical practice statementAnand Rohatgi, Sonia S Anand, Meghana Gadgil, et al.
Eclinicalmedicine|June 14, 2019
Cerebral Blood Perfusion Predicts Response to Sertraline versus Placebo for Major Depressive Disorder in the EMBARC TrialCrystal M Cooper, Cherise R Chin Fatt, Manish Jha, et al.
Pageof 5